The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: real-world insights from TARGET-DERM AD

被引:0
作者
Silverberg, Jonathan, I [1 ]
Knapp, Keith D. [2 ]
Munoz, Breda [2 ]
Crawford, Julie M. [2 ]
Calimlim, Brian [3 ]
Grada, Ayman [3 ]
Paller, Amy S. [4 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA
[2] Target RWE, Durham, NC USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Northwestern Feinberg Sch Med, Chicago, IL USA
关键词
atopic dermatitis; itch; patient-reported outcomes; quality-of-life; real-world evidence;
D O I
10.1093/bjd/ljad162.041
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
421
引用
收藏
页数:2
相关论文
共 33 条
[31]   Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece [J].
Gatopoulou, Anthia ;
Christodoulou, Dimitrios K. ;
Katsanos, Konstantinos H. ;
Bakos, Dimitrios ;
Mouzas, Ioannis ;
Tzouvala, Maria ;
Theodoropoulou, Angeliki ;
Paspatis, Gregorios ;
Theocharis, George ;
Thomopoulos, Konstantinos ;
Giouleme, Olga ;
Kourikou, Anastasia ;
Manolakopoulos, Spilios ;
Zampeli, Evanthia ;
Michopoulos, Spyros ;
Karatzas, Pantelis ;
Katsaros, Marios ;
Moschovis, Dimitris ;
Orfanoudaki, Eleni ;
Livieratos, Achilleas ;
Petrikkou, Evangelia ;
Mantzaris, Gerassimos J. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 :E615-E624
[32]   Androgen deprivation therapy in advanced prostate cancer: insights from a real-world patient survey on health-related quality of life and information and communication sources [J].
Bultijnck, Renee ;
De Laere, Luc ;
De Grande, Rony ;
Develter, Thijs ;
Vantieghem, Sophie ;
Uvin, Pieter ;
Ghysel, Christophe ;
De Laere, Bram .
QUALITY OF LIFE RESEARCH, 2024, 33 (09) :2553-2562
[33]   Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis [J].
Blauvelt, Andrew ;
Kircik, Leon ;
Schlesinger, Todd ;
Pierce, Evangeline ;
Burge, Russel ;
Behling, Michael ;
Atwater, Amber Reck ;
Elmaraghy, Hany ;
Armstrong, April .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)